Straumann Holding AG (STMN.SW)

111.30 -2.35 (-2.07%) At close: 05:30PM CEST

Straumann Holding AG

Peter Merian-Weg 12
Basel 4002
Switzerland
41 61 965 11 11
https://www.straumann.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 10,554

Description

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Corporate governance

Straumann Holding AG’s ISS governance QualityScore as of 1 June 2024 is 3. The pillar scores are Audit: 1; Board: 5; Shareholder rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.